ÂÜÀòÂÒÂ×

Peter Goldschmidt currently serves as the Chief Executive Officer of STADA Group since September 2018 and as Chairman of the Supervisory Board for SCHOTT Pharma since April 2023. Prior to these roles, Peter Goldschmidt was the President of Sandoz US and Head of North America from 2009 to March 2018, where leadership contributed to significant growth in the generic and biosimilar sectors. Earlier experience includes holding leadership positions within Novartis, focusing on markets in Central and Eastern Europe and managing operations in the Philippines, Singapore, and Indonesia. Peter Goldschmidt's educational background includes studies at the University of Münster, Harvard Business School, London Business School, and Stanford University Graduate School of Business.